Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 13 of 14, showing 10 Applications out of 131 total, starting on record 121, ending on 130

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

121.

ECCT/12/11/03   Rifampin-Based TB Treatment vs. Rifabutin-Based TB Treatment in HIV
    A5290 "A Randomized, Phase 2b Study of a Double-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifampin-Based Tuberculosis Treatment versus a Standard-Dose Lopinavir/Ritonavir-Based Antiretroviral Regimen with Rifabutin-Based Tuberculosis Treatment with or without Raltegravir in HIV-1-Infected Persons Requiring Treatment for Active TB and HIV"          
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
31-01-2012 View

122.

ECCT/12/11/02   Not provided
    A5297: An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of   Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
29-02-2012 View

123.

ECCT/12/03/01  
    Role of Fish Oil Omega-3 Fatty Acids on Depression among HIV-Seropositive Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial   
Principal Investigator(s)
1. Rose Okoyo Opiyo
Site(s) in Kenya
1. Riruta Health Centre (Nairobi City county)
2. Kariobangi North Health Centre (Nairobi City county)
3. Mathare North Health Centre (Nairobi City county)
4. Kayole II Sub-district hospital (Nairobi City county)
 
22-05-2012 View

124.

ECCT/11/12/02   VAC 46 Trial
    Efficacy Study of ChAd63-MVA ME-TRAP prime-boost Vaccination against Plasmodium falciparum infection.   
Principal Investigator(s)
1. Caroline Amolo Ogwang
Site(s) in Kenya
Junju Dispensary
 
19-12-2013 View

125.

ECCT/11/10/05  
    A Phase 3, Open Label, Randomized, Comparative Study to Evaluate Azithromycin Plus Chloroquine and Sulfadoxine Plus Pyrimethamine Combinations for Intermittent Preventive Treatment of Falciparum Malaria Infection in Pregnant Women in Africa. WRAIR #1775, KEMRI SSC #1983   
Principal Investigator(s)
1. Lucas Otieno Tina
Site(s) in Kenya
1. KEMRI/WRP Kombewa (Kisumu county)
 
25-11-2011 View

126.

ECCT/11/10/01  
    A RANDOMIZED PHASE IIA TRIAL OF GEMCITABINE COMPARED WITH  BLEOMYCIN PLUS VINCRISTINE FOR TREATMENT OF KAPOSI’S SARCOMA IN PATIENTS ON COMBINATION ANTIRETROVIRAL THERAPY IN WESTERN KENYA.   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH SITE
 
20-07-2011 View

127.

ECCT/11/08/05   Rifapentine During Intensive Phase TB Treatment
        Evaluation of a rifapentine-containing regimen for intensive phase treatment of pulmonary tuberculosis   
Principal Investigator(s)
1. Lena Matata
2. Kevin Cain
Site(s) in Kenya
KEMRI/CDC-KISUMU
 
02-11-2011 View

128.

ECCT/11/04/01  
    A Double-blind, Randomized Trial of Monthly Treatment with Metronidazole and Miconazole Co-formulated Suppositories versus Placebo for Preventing Vaginal Infections in HIVSeronegative Women (DMID Protocol Number: 09-0070)   
Principal Investigator(s)
1. Raymond Scott McClelland
Site(s) in Kenya
1. Kenya AIDS Vaccine Initiative (Nairobi City county)
2. Kenya AIDS Control Program (Nairobi City county)
3. Mombasa HIV/STD Research Clinic (Mombasa county)
 
23-06-2011 View

129.

ECCT/10/09/05   A5225/ HiFLAC
    A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis       A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)   
Principal Investigator(s)
1. Deborah Chepngeno langat
Site(s) in Kenya
1.
 
08-02-2013 View

130.

ECCT/10/03/03   High-Dose Fluconazole Treatment in AIDS-Associated CM
    A5225/HiFLAC: A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
11-05-2012 View